Curcuminoid compounds show promise against COVID-19 in neuronal cells

FHS
May 14, 2024
11:18 am

The effects of curcumin and curcuminoids on a human neuroblastoma cell line (SH-SY5Y) infected with SARS-CoV-2.

Camena bags $10m in funding from Mercia – Pharmaceutical Technology

Camena’s technology aims to provide a highly accurate enzyme-based DNA synthesis. Image credit: Andriy Onufriyenko via Getty Images. Camena Bioscience, a synthetic biology company that

July 3, 2023

With new results at ASCO, Enhertu once again rewrites rules of breast cancer treatment

CHICAGO — The cancer drug Enhertu stalled the growth of tumors by more than a year, significantly longer than standard chemotherapy did in women with

June 2, 2024

Ono Pharmaceutical partners with EME for antibody drug discovery

Share this article Ono will carry out testing to assess the in vitro and in vivo assay activities of the antibodies. Credit: Alexander Raths /

February 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.